A randomized, double-blind trial evaluating the safety and immunogenicity of an influenza vaccine with reduced preservative (FluLaval TR) [SPD 707] and a standard influenza vaccine (Fluarix) in subjects between 18-60 and over 60 years of age

Trial Profile

A randomized, double-blind trial evaluating the safety and immunogenicity of an influenza vaccine with reduced preservative (FluLaval TR) [SPD 707] and a standard influenza vaccine (Fluarix) in subjects between 18-60 and over 60 years of age

Completed
Phase of Trial: Phase III

Latest Information Update: 11 Oct 2016

At a glance

  • Drugs GSK 1536489A; Influenza virus vaccine
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 26 Feb 2009 Additional locations identified as reported by ClinicalTrials.gov, last updated 26 Feb 2009.
    • 09 May 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top